Human thrombin topical - Grifols

Drug Profile

Human thrombin topical - Grifols

Alternative Names: Topical Thrombin (Human) Grifols

Latest Information Update: 23 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Grifols
  • Class Antifibrinolytics; Antihaemorrhagics; Blood coagulation factors; Coagulants; Serine endopeptidases
  • Mechanism of Action Blood coagulation stimulants; Thrombin replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Surgical blood loss

Most Recent Events

  • 23 Mar 2017 No recent reports of development identified - Phase-II for Surgical blood loss (Prevention) in USA (Topical)
  • 01 Nov 2015 Grifols completes a phase II trial for Surgical blood loss (Prevention) in USA (NCT02014402)
  • 17 Feb 2014 Phase-II clinical trials in Surgical blood loss (prevention) in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top